Comparative study of three brands of antidiabetic drug, empagliflozin available in Karachi, Pakistan

Empagliflozin is a newer oral antidiabetic drug that treats people who have type-II Diabetes Mellitus. Empagliflozin reduces the reabsorption of filtered glucose and increases urine glucose excretion. The objective of the study is to analyze the physiochemical equivalence of different brands of Emp...

Full description

Bibliographic Details
Main Authors: Khadija Aslam, Safila Naveed, Fatima Qamar, Halima Sadia, Muhammad Ulusyar Khan, Tajala Aman
Format: Article
Language:English
Published: University of Faisalabad 2023-04-01
Series:Journal of University Medical & Dental College
Subjects:
Online Access:https://jumdc.com/index.php/jumdc/article/view/781

Similar Items